世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038467

組織診断薬市場調査レポートー2032年までの市場予測

Market Research Future

Tissue Diagnostics Market Research Report - Market Forecast till 2032

発刊日 2024/05

言語英語

体裁PDF/128ページ

ライセンス/価格128ページ

0000038467

Single
Multiuser
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

組織診断薬市場調査レポート::製品別情報 (機器、試薬、消耗品)、技術別 (免疫組織化学、In-situハイブリダイゼーション、デジタルパソロジーおよびワークフロー管理、およびその他の技術)、用途別(乳がん、前立腺がん、胃がん、およびその他のがん)、地域別 (北米、欧州、アジア太平洋、およびその他の地域)-2032年までの市場予測

組織診断の世界市場の概要

組織診断薬の市場規模は、2023年に54億ドルと評価されました。この市場は、2024年の61億ドルから2032年までに148億ドルに成長し、予測期間(2024年から2032年)の間に13.50%のCAGRを示すと予測されます。組織診断市場は、乳がんや肺がんを含むさまざまな種類のがんの発生率の上昇など、重要な市場推進要因により、予測期間を通じて成長する予想されます。

レポート詳細

目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL TISSUE DIAGNOSTICS MARKET, BY PRODUCT
6.1. Overview
6.2. Instruments
6.3. Reagents & Consumables

7. GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1. Overview
7.2. Immunohistochemistry
7.3. In-situ Hybridization
7.4. Digital Pathology and Workflow Management
7.5. Other Technologies

8. GLOBAL TISSUE DIAGNOSTICS MARKET, BY APPLICATION
8.1. Overview
8.2. Breast Cancer
8.3. Prostate Cancer
8.4. Gastric Cancer
8.5. Other Cancers

9. GLOBAL TISSUE DIAGNOSTICS MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Tissue Diagnostics Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Tissue Diagnostics Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. BioGenex Laboratories
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Agilent Technologies Inc.
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. ILLUMINA Inc.
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Merck KGa
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Danaher Corporation
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. F. Hoffmann-La Roche Ltd
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Qiagen NV
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Thermo Fisher Scientific Inc.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL TISSUE DIAGNOSTICS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL TISSUE DIAGNOSTICS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 US: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 US: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 11 US: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 12 CANADA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 13 CANADA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 14 CANADA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 7 FRANCE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 FRANCE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 10 ITALY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 11 ITALY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 12 ITALY: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 13 SPAIN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 14 SPAIN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 15 SPAIN: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 16 UK: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 17 UK: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 18 UK: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 25 JAPAN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 26 JAPAN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 27 JAPAN: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 28 CHINA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 29 CHINA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 30 CHINA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 31 INDIA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 32 INDIA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 33 INDIA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 34 AUSTRALIA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 35 AUSTRALIA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 36 AUSTRALIA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 49 AFRICA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 50 AFRICA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 51 AFRICA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL TISSUE DIAGNOSTICS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL TISSUE DIAGNOSTICS MARKET
FIGURE 4 GLOBAL TISSUE DIAGNOSTICS MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 5 GLOBAL TISSUE DIAGNOSTICS MARKET, SHARE (%), BY TECHNOLOGY, 2023
FIGURE 6 GLOBAL TISSUE DIAGNOSTICS MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 7 GLOBAL TISSUE DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: TISSUE DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL TISSUE DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 ABBOTT LABORATORIES: SWOT ANALYSIS
FIGURE 15 BIOGENEX LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 BIOGENEX LABORATORIES: SWOT ANALYSIS
FIGURE 17 AGILENT TECHNOLOGIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 AGILENT TECHNOLOGIES INC.: SWOT ANALYSIS
FIGURE 19 ILLUMINA INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 ILLUMINA INC.: SWOT ANALYSIS
FIGURE 21 MERCK KGA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 MERCK KGA: SWOT ANALYSIS
FIGURE 23 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 DANAHER CORPORATION: SWOT ANALYSIS
FIGURE 25 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 27 QIAGEN NV: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 QIAGEN NV: SWOT ANALYSIS
FIGURE 29 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS

この商品のレポートナンバー

0000038467

TOP